Filing Details
- Accession Number:
- 0001127602-10-010293
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-02 13:00:00
- Reporting Period:
- 2010-04-01
- Filing Date:
- 2010-04-02
- Accepted Time:
- 2010-04-02 16:21:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1231615 | Roger Jeffs | President & Coo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-04-01 | 8,000 | $22.37 | 26,968 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-04-01 | 8,000 | $55.03 | 18,968 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2010-04-01 | 8,000 | $0.00 | 8,000 | $22.37 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,000 | 2005-12-15 | 2014-12-15 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 3,966 | Direct |
Footnotes
- Shares held by a family limited liability company of which the reporting person and his spouse are managing members.
- The exercise of stock options and the corresponding sale of 8,000 shares are pursuant to the 10b5-1 Plan adopted by the reporting person on June 1, 2009.
Billionaire Hedge Funds
